2025 Winners
Now in its 14th year, Outsourced Pharma’s CDMO Leadership Awards will introduce new categories and an enhanced scoring methodology, developed in collaboration with our research partner, Orientation Marketing.
289 survey respondents evaluated 210 different CDMOs (respondents could only evaluate companies they have worked with the past 24 months). A proprietary scoring system blended Net Promoter Scores (NPS) with a "Top 3 Ranking" from survey respondents. Each CDMO receives a final weighted score with only those exceeding a qualification threshold within their modality named as a winner.
These categories are further divided to recognize top CDMOs in each of three regions: Global – facilities both inside and outside of the U.S.; International – facilities outside the U.S. only; and North American – facilities inside the U.S. only.
|
Global |
International |
North American |
|
Champion Abzena |
Champion Mabion |
Champion Macrogenics |
|
|
|
|
Global |
International |
North American |
|
Champion GenScript Biotech |
Champion 3P Bioivian |
Champion Aldevron |
|
|
|
|
Global |
International |
North American |
|
Champion Esteve |
Champion PROCOS S.P.A. |
Champion Sterling Pharma Solutions |
|
|
|
|
Global |
International |
North American |
|
Champion BioDuro |
Champion Upperton |
Champion Bend Bioscience |
|
|
|
Juried & Best In Class Awards
In addition to the CDMO Leadership Awards, Outsourced Pharma's Juried and Best In Class Awards capture more of what the CDMO industry and professionals excel at every day.
Juried Award finalists and winners were voted on by a panel if industry professionals. Three of these categories represent the suppliers and partners that provide CDMOs with the equipment, technology, support and know-how to allow them to focus on delivering quality results for their customers. A fourth Juried Award recognizes the best new or transformed CDMO in the last year.
Best In Class Awards recognize additional qualities sponsors value when selecting a partner. Finalists and winners were calculated using the same survey results that support the Leadership Awards.
|
Best Private Equity Team in the CDMO Industry |
Most Promising Drug Delivery Technology |
Best New or Transformed CDMO |
|
2025 Nominees
|
2025 Nominees
|
2025 Nominees
|
|
Winner GHO Capital Partners |
Winners (Tie) NanoformandNanomi |
Winner Bora Pharmaceuticals |
|
Best Manufacturing Capabilities |
Best Scientific Expertise |
Best On-Time Delivery |
|
2025 Nominees
|
2025 Nominees
|
2025 Nominees
|
|
Winner AGC Pharma Chemicals |
Winner WuXi Biologics |
Winner Flamma |
|
Best Seamless Delivery Across Phases |
Best Quality Management Systems |
Best Innovative Approach to Technology and Process Execution |
|
2025 Nominees
|
2025 Nominees
|
2025 Nominees
|
|
Winner WuXi Biologics |
Winner AGC Biologics |
Winner WuXi Biologics |
|
Best Facilities |
||
|
2025 Nominees
|
||
|
Winner Samsung Biologics |
2025 Awards Ceremony
In March 2025, Outsourced Pharma, Life Science Connect, and Orientation Marketing celebrated the hard working - and often unrecognized - outsourcing partners and players who bring life saving therapies to market with the annual CDMO Leadership Awards. Louis Garguilo, Chief Editor of Outsourced Pharma, hosted the event. Now available on-demand — check out the presentation and recognition of the 2025 CDMO Leadership Award winners. Thanks to our sponsors Federal Equipment Company, Master Control, CAI, and Ecolab Life Sciences for helping make this awards ceremony and reception possible.